SPY767.29−0.53%QQQ738.07−0.86%BTC/USD83,928.88−0.61%DIA515.28−0.43%GLD379.25−3.60%TLT78.61−0.90%
Benzinga

Collegium Pharmaceutical Inc (COLL) Stock Price, Quote, News & History

COLLNASDAQ
Trade with Public
Trade with Public
$22.75
0.220.98%
Last update: Sep 28, 1:56 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Collegium Pharmaceutical (COLL) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$22.63
Close
-
Volume / Avg.
179.23K / 714.64K
Day Range
$22.36 - $23.17
52 Wk Range
21.65 - 50.79
Market Cap
$705.23M
P/E Ratio
17.74
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
22.08%
Days to Cover
6.03

Recent Collegium Pharmaceutical, Inc. News

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In Q3

Healthcare stocks UTHR, COLL and AHG show oversold RSI levels near or below 30, potentially offering undervalued buying opportunities.
Avi Kapoor

5 Hot Stocks With Summer Buybacks You Can Cash In On

Stock buybacks remain one of the most effective tools for boosting share prices, especially when backed by solid fundamentals. When a company is healthy, repurchasing shares reduces the float, enhances earnings per
MarketBeat

Collegium's Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham

Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, and undervaluation.
Nabaparna Bhattacharya

S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Why Collegium Pharmaceutical Shares Are Gaining Today

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial 
Akanksha Bakshi

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
329.92M
Investing Cash Flow (TTM)
-551.90M
Financing Cash Flow (TTM)
234.11M
Free Cash Flow (TTM)
328.28M
Capital Expenditure (TTM)
-1.64M
Net Change in Cash (TTM)
12.13M

Analyst Trends and Forecast

2
1
Aug
3
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.70B
PE Ratio (TTM)
17.74
PE Ratio (FWD)
3.31
PEG Ratio (TTM)
0.66
PS Ratio (TTM)
1.01
PB Ratio (TTM)
2.35
Earnings Yield % (TTM)
5.64%
Earnings Yield % (FWD)
30.25%
EV / EBITDA (TTM)
4.39
Price / EBITDA (TTM)
2.10
Price / Free Cash Flow (TTM)
2.48
Book Value / Share
$9.58

Company Debt

Total Debt
$1.09B
LT Debt
$1.04B
LT Debt Issuance (TTM)
$864.68M
LT Debt Repayment (TTM)
-$617.77M
Total Cash
$129.47M
Debt to Equity
3.52
Issuance of Debt (TTM)
$246.91M
Repayment of Debt (TTM)
-$617.77M

Key Statistics

Open
$22.63
Close
-
Volume / Avg.
179.23K / 714.64K
Day Range
$22.36 - $23.17
52 Wk Range
21.65 - 50.79
Market Cap
$705.23M
P/E Ratio
17.74
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
22.08%
Days to Cover
6.03

About

Sector
Health Care
Industry
Pharmaceuticals
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Collegium Pharmaceutical (COLL) stock?

A

You can purchase shares of Collegium Pharmaceutical (NASDAQ:COLL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Collegium Pharmaceutical (COLL) competitors?

Q

What is the forecast, or price target, for Collegium Pharmaceutical (COLL) stock?

A

Collegium Pharmaceutical has a consensus price target of $47.27.

Q

What is the current price for Collegium Pharmaceutical (COLL)?

A

The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $22.75 last updated September 28, 2026 at 1:56 PM EDT.

Q

Does Collegium Pharmaceutical (COLL) pay a dividend?

A

There are no upcoming dividends for Collegium Pharmaceutical.

Q

When is Collegium Pharmaceutical (NASDAQ:COLL) reporting earnings?

A

Collegium Pharmaceutical does not have any upcoming earnings scheduled.

Q

Is Collegium Pharmaceutical (COLL) going to split?

A

There is no upcoming split for Collegium Pharmaceutical.

Q

What sector and industry does Collegium Pharmaceutical (COLL) operate in?

A

Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved